- Home
- ABSI vs IGD Comparison
ABSI vs IGD Comparison
Compare ABSI & IGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABSI
- IGD
- Stock Information
- Founded
- ABSI 2011
- IGD N/A
- Country
- ABSI United States
- IGD United States
- Employees
- ABSI N/A
- IGD N/A
- Industry
- ABSI Biotechnology: Pharmaceutical Preparations
- IGD Trusts Except Educational Religious and Charitable
- Sector
- ABSI Health Care
- IGD Finance
- Exchange
- ABSI Nasdaq
- IGD Nasdaq
- Market Cap
- ABSI 457.6M
- IGD 437.7M
- IPO Year
- ABSI 2021
- IGD N/A
- Fundamental
- Price
- ABSI $2.56
- IGD $5.56
- Analyst Decision
- ABSI Strong Buy
- IGD
- Analyst Count
- ABSI 6
- IGD 0
- Target Price
- ABSI $8.67
- IGD N/A
- AVG Volume (30 Days)
- ABSI 1.5M
- IGD 215.3K
- Earning Date
- ABSI 11-12-2024
- IGD 01-01-0001
- Dividend Yield
- ABSI N/A
- IGD 9.15%
- EPS Growth
- ABSI N/A
- IGD N/A
- EPS
- ABSI N/A
- IGD N/A
- Revenue
- ABSI $4,207,000.00
- IGD N/A
- Revenue This Year
- ABSI $9.36
- IGD N/A
- Revenue Next Year
- ABSI $198.59
- IGD N/A
- P/E Ratio
- ABSI N/A
- IGD N/A
- Revenue Growth
- ABSI N/A
- IGD N/A
- 52 Week Low
- ABSI $1.35
- IGD $4.60
- 52 Week High
- ABSI $6.72
- IGD $5.26
- Technical
- Relative Strength Index (RSI)
- ABSI 24.85
- IGD 53.69
- Support Level
- ABSI $2.45
- IGD $5.52
- Resistance Level
- ABSI $4.47
- IGD $5.59
- Average True Range (ATR)
- ABSI 0.28
- IGD 0.06
- MACD
- ABSI -0.13
- IGD 0.01
- Stochastic Oscillator
- ABSI 5.46
- IGD 83.33
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About IGD Voya Global Equity Dividend and Premium Opportunity Fund
Voya Global Equity Dividend and Premium Opportunity Fund are a United States-based diversified, closed-end Fund. The primary objective of the Fund is to seek to provide investors with a high level of income from a portfolio of common stocks with historically attractive dividend yields and premiums from call option writing. The secondary investment objective of the company is capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its managed assets in a portfolio of common stocks of dividend-paying companies located throughout the world.